Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Ekso Bionics Holdings (EKSO) Operating Expenses (2016 - 2026)

Ekso Bionics Holdings has reported Operating Expenses over the past 14 years, most recently at $6.2 million for Q4 2025.

  • On a quarterly basis, Operating Expenses rose 25.0% to $6.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $20.2 million, a 1.0% increase, with the full-year FY2025 number at $20.2 million, up 1.0% from a year prior.
  • Operating Expenses reached $6.2 million in Q4 2025 per EKSO's latest filing, up from $4.0 million in the prior quarter.
  • The five-year high for Operating Expenses was $7.0 million in Q4 2021, with the low at $4.0 million in Q3 2025.
  • The 5-year median for Operating Expenses is $5.2 million (2024), against an average of $5.3 million.
  • Peak YoY movement for Operating Expenses: surged 59.87% in 2021, then fell 23.95% in 2024.
  • Tracing EKSO's Operating Expenses over 5 years: stood at $7.0 million in 2021, then fell by 12.24% to $6.1 million in 2022, then dropped by 4.84% to $5.8 million in 2023, then fell by 15.02% to $4.9 million in 2024, then grew by 25.0% to $6.2 million in 2025.
  • According to Business Quant data, Operating Expenses over the past three periods came in at $6.2 million, $4.0 million, and $4.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.